Barclays’s Imperva, Inc. IMPV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-145
| Closed | -$8K | – | 7629 |
|
|
2018
Q4 | $8K | Sell |
145
-1,169
| -89% | -$63.5K | ﹤0.01% | 6302 |
|
|
2018
Q3 | $61K | Sell |
1,314
-382
| -23% | -$18.5K | ﹤0.01% | 5955 |
|
|
2018
Q2 | $82K | Sell |
1,696
-14,216
| -89% | -$680K | ﹤0.01% | 5373 |
|
|
2018
Q1 | $688K | Buy |
15,912
+14,566
| +1,082% | +$654K | ﹤0.01% | 3625 |
|
|
2017
Q4 | $53K | Sell |
1,346
-3,073
| -70% | -$128K | ﹤0.01% | 5726 |
|
|
2017
Q3 | $192K | Sell |
4,419
-7,735
| -64% | -$353K | ﹤0.01% | 4465 |
|
|
2017
Q2 | $581K | Buy |
12,154
+8,071
| +198% | +$376K | ﹤0.01% | 3368 |
|
|
2017
Q1 | $167K | Sell |
4,083
-8,738
| -68% | -$365K | ﹤0.01% | 4487 |
|
|
2016
Q4 | $492K | Buy |
12,821
+10,349
| +419% | +$420K | ﹤0.01% | 3389 |
|
|
2016
Q3 | $133K | Buy |
2,472
+2,002
| +426% | +$92.9K | ﹤0.01% | 4305 |
|
|
2016
Q2 | $20K | Sell |
470
-225
| -32% | -$9.44K | ﹤0.01% | 5279 |
|
|
2016
Q1 | $34K | Sell |
695
-2,163
| -76% | -$104K | ﹤0.01% | 4989 |
|
|
2015
Q4 | $180K | Sell |
2,858
-398
| -12% | -$27.1K | ﹤0.01% | 3991 |
|
|
2015
Q3 | $212K | Sell |
3,256
-6,744
| -67% | -$447K | ﹤0.01% | 4106 |
|
|
2015
Q2 | $671K | Sell |
10,000
-1,239
| -11% | -$68.4K | ﹤0.01% | 3231 |
|
|
2015
Q1 | $475K | Buy |
11,239
+9,980
| +793% | +$444K | ﹤0.01% | 3658 |
|
|
2014
Q4 | $61K | Buy |
1,259
+425
| +51% | +$17K | ﹤0.01% | 5564 |
|
|
2014
Q3 | $23K | Sell |
834
-35,060
| -98% | -$952K | ﹤0.01% | 6410 |
|
|
2014
Q2 | $933K | Buy |
35,894
+25,941
| +261% | +$670K | ﹤0.01% | 3401 |
|
|
2014
Q1 | $548K | Sell |
9,953
-3,834
| -28% | -$221K | ﹤0.01% | 3871 |
|
|
2013
Q4 | $662K | Buy |
13,787
+10,267
| +292% | +$432K | ﹤0.01% | 3822 |
|
|
2013
Q3 | $147K | Buy |
3,520
+784
| +29% | +$37.3K | ﹤0.01% | 5310 |
|
|
2013
Q2 | $123K | Buy |
+2,736
| New | +$107K | ﹤0.01% | 5618 |
|
Barclays's IMPV Position: Q1 2019 in Review
Barclays sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 145 shares — an estimated $8K sold.
Barclays first reported a position in IMPV in Q2 2013 and held it in 23 quarters. The position peaked at $933K in Q2 2014. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.
- Barclays reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
- Barclays sold 145 Imperva, Inc. shares in Q1 2019, an estimated $8K.
- Barclays first reported a position in Imperva, Inc. in Q2 2013 and held it in 23 quarters.
- Barclays's Imperva, Inc. position peaked at $933K in Q2 2014.
- 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.
Based on Barclays's 13F filing for Q1 2019, filed 15 May 2019.